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Abstract
Background: Tuberculosis (TB) control is based on early detection and complete treatment of infectious cases.
Consequently, it is important that TB suspects and patients can readily access medical care. This qualitative study
investigated determinants of access to DOTS services as identified by patients, health providers and community
members in four districts in Tajikistan.
Findings: Focus group discussions were conducted in order to investigate access to TB services. A conceptual
framework for access to care guided the analysis. Thirteen focus group discussions involving a total of 97
informants were conducted. Content analysis of discussions and a rating to quantify the relative importance of
discussed factors were carried out. The conceptual framework identifies five main components of access to which
factors can be assigned: availability, adequacy, acceptability, accessibility and affordability.
Financial factors were considered the most important determinants of access to diagnosis and treatment of
tuberculosis. Expenditure for drugs and consultations, for transport, and for special foods as well as lost income
were identified as major barriers to treatment. Stigma, doubts about curability and low perceived quality of care
were not seen to be significant determinants of access to care for tuberculosis. Community members were well
aware of symptoms of tuberculosis and of medical services. These findings were consistent between different
respondent groups (community members, patients and providers). They were also highly consistent between the
open discussion and the confidential rating.
Conclusions: Illness-costs to households were identified as the main barrier to tuberculosis diagnosis and
treatment. To improve access and ultimately adherence to tuberculosis treatment, effective mitigation strategies, e.
g. changes in case management, food contributions or financial stimuli, need to be explored and implemented.
Background
Tuberculosis (TB) cases often delay seeking care even
when chemotherapy is free of charge[1,2] and defaulting
from treatment is frequent. Irregular drug intake and
default can lead to further transmission of TB and drug-
resistance[3]. Some of the countries with the highest
rates of drug-resistant TB are in Central Asia, making
treatment adherence even more important in this region
[4]. In order for patients to present timely for diagnosis
and for TB cases to be able to adhere to the full treat-
ment, access to care is key. In fact, access has been
called “the most important determinant of the outcome
of treatment of TB”[5].
In many contexts, TB is linked to stigma and/or per-
ceived to be incurable[6-10]. For those patients believing
their illness to have supernatural causes, common sense
dictates that they would not utilise biomedical health
care. However, in rural Haiti, providing social support
had a strong positive influence on adherence, whereas
no influence of sorcery beliefs was found[11]. In urban
Bolivia, structural barriers including hidden costs of
treatment were more important determinants of adher-
ence than socio-cultural factors[12]. TB cases encoun-
tered substantial costs already before their diagnosis
[13,14], and TB suspects with lower income were less
likely to present to a doctor[15]. At large, there are
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TB - which ones are the actual determinants is debated.
Tajikistan has seen the breakdown of the previously
comprehensive health system. Health care workers are
badly paid and poorly motivated. Often patients have to
pay for health services that are stipulated to be free of
charge. Tajikistan adopted the DOTS strategy in 2002
and reported 79% DOTS coverage, 33% case detection
and 84% treatment success in 2006[16,17]. A study
found that patients in Tajikistan face average costs of
about 4’900USD purchasing power parity (PPP) per TB
episode[18]-in a country with a per capita gross domes-
tic product of 1’300USD PPP at the time of the study
[19].
The objective of this study was to identify the factors
with the strongest influence on access to tuberculosis
services - from the point of view of community mem-
bers, TB patients and health services providers.
Setting, study population and analytical
framework
The present study received ethical approval from the
Ministry of Health of Tajikistan. It was conducted in the
four pilot districts of Project Sino, which supported the
integration of TB services into primary care, funded by
the Swiss Agency for Development and Cooperation.
DOTS implementation in these districts started in 2004
(Danghara and Varzob) and 2005 (Shahrinaw and Tur-
sunzoda). TB laboratory services and treatment are
available at DOTS-centres in each district centre. Pri-
mary care facilities are allowed to diagnose TB but vir-
tually always refer suspects to the DOTS-centres for
diagnosis[1]. Primary care facilities are requested to
provide treatment supervision and follow-up if patients
do not present for treatment supervision.
We used a previously described analytical framework
of access to care in contexts of livelihood insecurity[20].
Our analysis focussed on access and did no go into
details of livelihoods. Availability was not covered, as TB
services were known to be available at DOTS-centres.
The resulting adapted analytical framework organised
factors in four categories: accessibility, affordability,
acceptability and adequacy. (Table 1). First, content ana-
lysis was conducted. Second, the number of statements
relating to each of the four categories were summed up
and expressed as a percentage along the three respon-
dent groups. There were hardly any statements relating
to adequacy and therefore only the other three cate-
gories are presented in the results. Third, results of the
rating were analysed by calculating the proportion of
chickpeas allocated to each factor, whereby each FGD
was equally weighted, independent of the number of
participants. The four categories from the content analy-
sis were further divided into twelve sub-categories
(Table 1).
Focus Group Discussions
Thirteen focus group discussions (FGDs) were con-
ducted in 2006 to investigate factors influencing access
to care for tuberculosis. Five FGDs were conducted with
community members, four with TB patients and four
with health services providers to cover experiences of
stakeholders involved in TB treatment. Stratification
along different criteria was used to obtain more valid
results (Table 2). Participants were invited by the
research team, ensuring different ages were represented.
Table 1 Analytical framework used in this study for factors influencing access to care†
Main
categories
Affordability Acceptability Accessibility* Adequacy*
Sub-
categories
(and
examples)
▪ Missed opportunities (lost income
due to inability to work)
▪ Side effects of treatment ▪ Distance to facility (effort
to cover distance, time
needed)
▪ Organisational
appropriateness of
services
▪ Medical costs (costs for diagnostic
tests, drugs, etc.)
▪ Perceived quality of care (technical
specialisation of providers)
▪ Physical state and
cleanliness of
facilities
▪ Non-medical costs (transportation
costs, expenditure for disease-related
diets, etc.)
▪ Attitude of providers (friendliness
of doctors)
▪ Convenient
opening hours
▪ Lack of confidentiality (other
community members find out about
TB patient)
▪ Health beliefs (lack of belief in
curability)
†Adapted from reference 20.
*In the participatory approach, factors relating to accessibility and adequacy were not regarded as important (no chickpeas allocated) and the results are
presented without these factors.
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identified through the TB patient registry and health
services providers were identified through staff lists.
Information on treatment adherence was incomplete. At
the time of invitation, patients were asked whether they
had been forced to interrupt treatment at any time.
Patients reporting irregular treatment intake were
included in the same FGD as defaulters. The research
team consisted of a moderator, a transcriber and two
observers. The moderator with a background in chemis-
try, community development and applied sociologic
research had previous experience with FGDs and an
outstanding ability to gain people’s trust and respect.
The FGDs covered the following topics: (i) symptoms
and causes of TB, (ii) perceived appropriateness of treat-
ment, (iii) factors determining the communities’ ability
to receive diagnosis and (iv) to complete treatment for
TB. At the beginning of the FGDs with community
members no hint to TB was given. Participants were
asked about diseases causing cough; subsequently intro-
ducing other symptoms like sputum production, fatigue,
weight loss, and night sweats. After the discussion on
diseases causing the named symptoms, the focus on TB
was disclosed to the participants. In FGDs with patients
and providers, the focus on TB was known from the
beginning.
After the discussion, participants of community and
patient FGDs were asked to rank the factors preventing
“people from receiving full medical treatment” by
importance in a participatory approach (’rating’), using
chickpeas to rank the perceived importance of different
factors. No rating was conducted among providers,
because it interfered with local concepts of professional-
ism. For the rating, all factors named during the discus-
sion on access to care were listed. The researchers
suggested the following potential factors whenever they
were not spontaneously mentioned: attitude of provi-
ders, insufficient confidentiality of medical services,
stigma of TB, attitude of other community members
towards TB patients and lost income. Each participant
was asked to confidentially allocate six, three and one
chickpea to the three most important factors.
FGDs were conducted in Tajik. Translation to the
minority languages Uzbek and Russian were provided by
the moderator and an observer as needed. All FGDs
were recorded on audiotape and transcribed to English.
The accuracy of the transcriptions was checked by the
main researcher who is fluent in Tajik and English.
Where needed, the whole team re-checked the tran-
scription by listening to the audiotape and by checking
their own notes taken during the FGDs. The main
researcher read the transcriptions repeatedly, categorised
the statements using the analytical framework described
above and added codes in TAMS Analyzer (version
3.31b2pt, Matthew Weinstein, 2005).
Study participants
Fourty-three community members participated in the
community FGDs, 21 women and 22 men with a mean
age of 42 years. Among providers, 15 doctors, nine
nurses and seven TB specialists participated (mean age
45 years). Of 23 patients, eight were women and 15
were men. Participants were mainly from rural areas
with about one fourth coming from semi-urban areas.
First the results from the discussion on characteristics
of TB and on barriers to treatment are presented and
then the relative importance of identified factors from
the rating. The topics that came up in the discussion on
access to diagnosis and on access to treatment were
very much the same. Participants also explicitly stated
that the same factors were important at both times.
Consequently the results are presented jointly.
Knowledge about TB
Upon presentation of symptoms of TB, community
members mentioned a number of respiratory diseases,
most prominently asthma, influenza and bronchitis.
Community members also mentioned TB soon in all
FGDs. Overall, knowledge of symptoms was accurate.
Community members were able to identify medical
facilities providing TB treatment in their surroundings.
Knowledge about causes of TB was limited. In particu-
lar the belief that TB was inherited and normally incur-
able was found commonly among community members
and also expressed by one patient and one provider.
These beliefs were closely linked to the stigmatisation of
t h ei l l n e s s .T h es t i g m aw a sm a g n i f i e db yt h ef a c tt h a t
TB services are offered in separate facilities.
Despite the misunderstandings on causes of TB and
prospects of care, all respondent groups deemed medical
Table 2 Eligibility criteria and stratification for the 13 focus group discussions, by respondent category
Community members Patients Providers
1) Women from small rural town 1) Women in treatment 1) Family doctors from Danghara
2) Men from remote rural village 2) Men in treatment 2) Nurses from Varzob
3) Women from rural village 3) Women and men after treatment success 3) Family doctors from Shahrinaw and Tursunzoda
4) Men from rural village 4) Defaulters and patients indicating irregular drug intake 4) TB specialists from all four districts
5) Women from semi-urban centre
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that they would seek medical care in case of illness.
Community members showed themselves well aware of
the availability of TB services at the DOTS centres.
Overall it was revealed that due to the difficulties asso-
ciated with accessing medical care, patients tended to
delay presenting until their health status had become
severe - despite community members being aware of
better prospects of cure at earlier presentation to care.
Factors determining access to care
Respondents in all FGDs agreed that financial factors
were the strongest determinants of access to care and
the patient’s ability to take the full treatment, i.e. adher-
ence. On the question, why people with TB do not get
treatment, a woman (teacher, 47 years old) from Varzob
town said: “No money, no treatment - money plays a
great role.” A general practitioner (40 years) from Dan-
ghara answered: “First, because of the financial situation,
because of the funds.” Other possible reasons were not
perceived to be equally important. Although stigma of
TB was acknowledged, most participants emphasized it
would not prevent patients from visiting medical facil-
ities. Side-effects of treatment were experienced by
some participating patients, but were not mentioned
very often and were considered important by a small
minority only.
The perceived higher importance of economic factors
relative to acceptability and accessibility of services was
also reflected in the number of statements among all
respondent groups (Figure 1). Factors relating to ade-
quacy of services were mentioned even less often and
are not presented here. Notably, factors relating to
acceptability of services were mentioned least often
among patients. Financial factors included all direct
costs and lost income. Geographical factors included the
effort for the patient to travel and time spent travelling.
It did not include transport costs and statements linking
travel time to money.
Community members allocated 12%, 62% and 20% of
chickpeas to the categories ‘missed opportunities’, ‘medi-
cal expenditure’ and ‘non-medical expenditure’ respec-
tively (Figure 2). Patients allocated 21%, 21% and 37% of
chickpeas to the same factors. Thus a total of 94% and
78% of chickpeas respectively were allocated to financial
factors. Factors related to acceptability unified only 11%
and 6% of chickpeas in patient and community FGDs,
respectively, despite the moderator carefully probing for
and explaining rational ways of action of these factors.
Factors contributing to costs
Costs mentioned in the FGDs can be grouped into six
categories: diagnosis, drugs and consultation, hospitalisa-
tion, transport, increased expenditure for food and lost
income. Diagnostic expenditure was seen to be less
important with the exception of radiography, which was
considered expensive by patients and community mem-
bers. Cost of drugs and consultation were identified as
important barriers by patients and especially by commu-
nity members (Figure 3). Three patients reported they
were asked to pay for the TB drugs. For the majority of
patients, ‘cost of drugs’ stands for additional, sympto-
matic treatment, like vitamin injections or intravenous
rehydration. Admission to hospital has received little
attention, probably because there is no admission fee.
Admission is however linked to expenditure for trans-
port and increased expenditure for food. Food for hospi-
talised patients has to be provided by caregivers such as
family members leading to higher food-related expendi-
ture during hospitalisation. Participants of the FGDs did
Figure 1 Frequency of statements referring to three components of access to care.
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food provision from the cost of the food itself.
Significance and implications
While several studies showed that patients face substan-
tial costs even where TB drugs are stipulated to be free
of charge[18,21-24], few previous studies have investi-
gated the relative importance of financial versus other
barriers to TB care. We investigated the influence of
various health system and household-related factors on
access to care for TB in Tajikistan. Community mem-
bers, patients and providers consistently reported that
illness costs to households determine access to diagnosis
and treatment to a large extent and deemed quality of
care, stigma and other factors less important. To our
knowledge, this is the first study to demonstrate that ill-
ness-related costs are experienced by a broad range of
stakeholders including health care providers as the
major determinant of access to TB treatment. It is note-
worthy that participants named the same factors as bar-
riers to diagnosis and to treatment. Moreover, they
stated that the same factors were important in both
situations.
The main limitation of this study is possible reporting
bias. Reporting bias, however, should be reduced in the
confidential participatory approach. The high consis-
tency between the open discussion and the participatory
approach lead us to believe that reporting bias was lim-
ited. At the time of study implementation, DOTS was
relatively new to two of the study districts. Further
improvements may have happened since then.
The predominance of financial factors corresponds
well to the results of the small number of previous stu-
dies investigating the importance of financial and a wide
range of other factors[11,12]. The importance of finan-
cial factors is amplified for community members by
their lack of awareness about anti-mycobacterial therapy
being offered free of charge. This is likely to influence
their health care seeking.
Enabling patients to obtain prompt diagnosis and full
treatment and thus interrupting the cycle of infection is
crucial. The results of this study suggest that doing so
requires a reduction of the costs faced by patients and
their households.
When designing strategies to reduce costs to patients,
it should be kept in mind, that components of access to
Figure 2 Relative importance of different barriers to tuberculosis treatment, measured by the proportion of chickpeas allocated by
participants of FGDs.
Figure 3 Relative importance of financial factors regarding
access to TB services, measured by the proportion of
chickpeas allocated by participants of FGDs.
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quality and reliability of food provided at the hospital
would reduce the need for patients’ relatives to travel on
ad a i l yb a s i st ob r i n gm e a l st o hospitalised patients.
Case management factors, like the provision of addi-
tional treatment besides the TB-medication, have been
found to cause substantial expenditures for TB patients
in Tajikistan[18]. Reviewing the rationality of such addi-
tional medication may be needed. For those cases,
where the latter is medically warranted, programs and
donors should aim at providing additional medication
for free, too. The highest costs, however, were related to
loss of income due to TB disease[18]. Social support
mechanisms including financial stimuli or-as is already
being done in Tajikistan-food complements are neces-
sary and may need to be expanded[11,25-27]. Insurance
schemes or formalised community support are options
to ease the financial hardship of disease, but need to be
carefully explored and designed[28]. In the longer term
and in contexts with good levels of accountability and
governance, such insurance schemes could potentially
contribute to improved adherence to TB treatment.
Longer delays to TB diagnosis are also associated with
higher costs[22,29]. Shortening delays would contribute
to lower expenditure as well as a reduction of the loss
of income associated with disease.
Concluding, it is difficult to increase TB case detection
and treatment adherence as long as patients’ immediate
concerns are not addressed. For TB control to be suc-
cessful in Tajikistan and many other countries, pro-
grams need to reduce financial barriers to TB treatment.
Possible ways to ease the financial hardship of TB for
affected households include among others changes in
case management, financial stimuli and food
supplements.
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